Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)691
JournalEuropean Journal of Heart Failure
Volume19
Issue number5
DOIs
Publication statusPublished - May 1 2017

Cite this

@article{260a70f657c342bd8b8cfa379520e9a5,
title = "Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation",
author = "Marco Guazzi",
year = "2017",
month = "5",
day = "1",
doi = "10.1002/ejhf.753",
language = "English",
volume = "19",
pages = "691",
journal = "European Journal of Heart Failure",
issn = "1388-9842",
publisher = "John Wiley & Sons, Ltd",
number = "5",

}

TY - JOUR

T1 - Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation

AU - Guazzi, Marco

PY - 2017/5/1

Y1 - 2017/5/1

UR - http://www.scopus.com/inward/record.url?scp=85011117665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011117665&partnerID=8YFLogxK

U2 - 10.1002/ejhf.753

DO - 10.1002/ejhf.753

M3 - Letter

AN - SCOPUS:85011117665

VL - 19

SP - 691

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1388-9842

IS - 5

ER -